What's fueling the biotech engine—2007
- 1 November 2008
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 26 (11) , 1227-1233
- https://doi.org/10.1038/nbt1108-1227
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Toward biosimilar monoclonal antibodiesNature Biotechnology, 2008
- Economic issues with follow-on protein productsNature Reviews Drug Discovery, 2008
- An HIV Vaccine — Challenges and ProspectsNew England Journal of Medicine, 2008
- Health and Economic Implications of HPV Vaccination in the United StatesNew England Journal of Medicine, 2008
- IL-1 trap go-aheadNature Biotechnology, 2008
- New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpuraEuropean Journal of Haematology, 2008
- Pfizer dumps ExuberaNature Biotechnology, 2007
- Complement-targeted therapeuticsNature Biotechnology, 2007
- What's fueling the biotech engine?Nature Biotechnology, 2007
- Erythropoietin, the FDA, and OncologyNew England Journal of Medicine, 2007